Evolent Health, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $-60.7M | $-159.7M | $332.5M | $-25.2M | $20.0M |
| Depreciation & Amortization | $32.4M | $17.2M | $7.2M | $0 | $1.2M |
| Depreciation | $9.2M | $2.6M | $1.2M | $0 | $800.0K |
| Amortization | $22.8M | $12.5M | $5.8M | $0 | $400.0K |
| Stock-Based Compensation | $20.4M | $18.6M | $14.7M | $0 | $91.0K |
| Net Cash from Operating Activities | $-28.0M | $-35.5M | $-18.5M | $0 | $-13.6M |
| Investing Activities | |||||
| Capital Expenditures | $27.8M | $15.5M | $6.5M | $0 | $10.4M |
| Business Acquisitions | $3.7M | — | — | — | — |
| Net Cash from Investing Activities | $-12.3M | $-96.7M | $-43.7M | $0 | $-25.9M |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — |
| Net Cash from Financing Activities | $165.6M | $150.2M | $214.2M | $0 | $34.3M |
| Net Change in Cash | $125.3M | $-11.2M | $145.7M | $0 | $-5.3M |
| Free Cash Flow | $-55.8M | $-51.0M | $-25.0M | $0 | $-24.1M |